Michael Levitz is a strategic, execution-driven Chief Financial Officer with more than 20 years of public- company medical device experience, including over a decade as CFO leading global, high-growth organizations. Recognized for driving enterprise value, operational excellence, and investor confidence at companies such as Insulet Corporation in diabetes care, Michael combines financial acumen with strategic vision. As a trusted advisor and values-based leader, Michael brings deep experience in finance, corporate governance and organizational performance, along with a passion for advancing medical innovation and empowering high-impact teams. In addition to serving on the board and as chairman of the audit committee of Kandu Inc., Michael is president of PTP Advisory LLC and serves on the advisory board of Thirdwayv Inc. Michael began his career in the high-technology audit practice of Arthur Andersen, is a certified public accountant, and has a degree in business economics with emphasis in accounting from the University of California at Santa Barbara.
